{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:56:06Z","timestamp":1777888566055,"version":"3.51.4"},"reference-count":42,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPD"],"published-print":{"date-parts":[[2021,10,12]]},"abstract":"<jats:p>Background: Recent research suggests that a significant number of those who receive advanced treatments for Parkinson\u2019s disease (PD) do not report improvements for some symptoms, which may relate to their pre-treatment expectations. It is important that expectations of treatment are measured and discussed prior to advanced treatment. Objective: The primary aim of this study was to develop a measure of treatment expectations of two advanced-stage treatments in PD, deep brain stimulation (DBS), and Levodopa\/Carbidopa Intestinal Gel (LCIG). A secondary aim was to explore potential predictors of treatment expectations. Methods: The questionnaire-based measure was developed by researchers in conjunction with a highly experienced clinician, and evaluated treatment expectations in 189 people aged 46\u201391 years (M\u200a=\u200a71.35, SD\u200a=\u200a8.73; 61% male) with idiopathic PD. Results: The overall measure demonstrated excellent internal consistency (\u03b1=\u200a0.96). Exploratory factor analysis suggested the scale was unidimensional for both DBS and LCIG. Participant expectations of the two treatments differed significantly, with expectations being higher for DBS. Perceived symptom severity was the strongest predictor of treatment expectations. Conclusion: This scale has potential to inform clinicians about client expectations prior to advanced stage therapy for PD, with a view to the management of these expectations. Further evaluation of the scale is required across different treatment contexts.<\/jats:p>","DOI":"10.3233\/jpd-212777","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T13:05:35Z","timestamp":1628255135000},"page":"2017-2026","source":"Crossref","is-referenced-by-count":0,"title":["Measuring General Expectations of Advanced Stage Treatment Outcomes in Parkinson\u2019s Disease"],"prefix":"10.1177","volume":"11","author":[{"given":"Andrea M.","family":"Loftus","sequence":"first","affiliation":[{"name":"Discipline of Psychology, School of Population Health, Curtin University, Perth, WA, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chloe","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Discipline of Psychology, School of Population Health, Curtin University, Perth, WA, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily J.","family":"Corti","sequence":"additional","affiliation":[{"name":"Discipline of Psychology, School of Population Health, Curtin University, Perth, WA, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Starkstein","sequence":"additional","affiliation":[{"name":"Faculty of Health and Medical Sciences, University of Western Australia, UWA Health Campus (QEII), Monash Avenue, Nedlands, WA, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Gasson","sequence":"additional","affiliation":[{"name":"Discipline of Psychology, School of Population Health, Curtin University, Perth, WA, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah J.","family":"Egan","sequence":"additional","affiliation":[{"name":"Discipline of Psychology, School of Population Health, Curtin University, Perth, WA, Australia"},{"name":"enAble Institute, Faculty of Health Sciences, Curtin University, Perth, WA, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JPD-212777_ref1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.parkreldis.2019.07.011","article-title":"Selecting candidates for deep brain stimulation in Parkinson\u2019s disease: The role of patients\u2019 expectations","volume":"66","author":"Geraedts","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-212777_ref2","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/jnnp-2012-303670","article-title":"Patients\u2019 expectations of deep brain stimulation and subjective perceived outcome related to clinical measures in Parkinson\u2019s disease: A mixed-method approach","volume":"84","author":"Maier","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JPD-212777_ref3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1086\/JCE201021204","article-title":"Hope and patients\u2019 expectations in deep brain stimulation: Healthcare providers\u2019 perspectives and approaches","volume":"21","author":"Bell","year":"2010","journal-title":"J Clin Ethics"},{"key":"10.3233\/JPD-212777_ref4","first-page":"409","article-title":"Neurosurgery in Parkinson\u2019s disease: The doctor is happy, the patient less so?","volume":"70","author":"Agid","year":"2006","journal-title":"J Neural Transm Suppl"},{"key":"10.3233\/JPD-212777_ref5","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/j.1460-9568.2010.07421.x","article-title":"Ethical brain stimulation neuro ethics of deep brain stimulation in research and clinical practice","volume":"32","author":"Clausen","year":"2010","journal-title":"Eur J Neurosci"},{"key":"10.3233\/JPD-212777_ref6","first-page":"S477","article-title":"Does the degree of improvement after deep brain stimulation surgery for Parkinson\u2019s disease (PD) meet the patient\u2019s expectations","volume":"33","author":"Candelario-Mckeown","year":"2018","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-212777_ref7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/1088868310368802","article-title":"Outcome expectancy and self-efficacy: Theoretical implications of an unresolved contradiction","volume":"14","author":"Williams","year":"2010","journal-title":"Pers Soc Psychol Rev"},{"key":"10.3233\/JPD-212777_ref8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.parkreldis.2010.09.005","article-title":"Measurement of patient centered outcomes in Parkinson\u2019s disease: What do patients really want from their treatment?","volume":"17","author":"Nisenzon","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-212777_ref9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1477-7525-12-11","article-title":"Perceptions of symptoms and expectations of advanced therapy for Parkinson\u2019s disease: Preliminary report of a Patient-Reported Outcome tool for Advanced Parkinson\u2019s disease (PRO-APD)","volume":"12","author":"Reddy","year":"2014","journal-title":"Health Qual Life Outcomes"},{"key":"10.3233\/JPD-212777_ref10","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1526-4637.2005.00059.x","article-title":"Multidimensional success criteria and expectations for treatment of chronic pain: The patient perspective","volume":"6","author":"Robinson","year":"2005","journal-title":"Pain Med"},{"key":"10.3233\/JPD-212777_ref11","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-212777_ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2010.08.012","article-title":"Determinants of health-related quality of life in Parkinson\u2019s disease: A systematic review","volume":"17","author":"Soh","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-212777_ref13","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.amjcard.2019.03.011","article-title":"Cardiac denial and expectations associated with depression in adults with congenital heart disease","volume":"123","author":"Huntley","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.3233\/JPD-212777_ref14","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1017\/S0033291718002106","article-title":"Why dysfunctional expectations in depression persist \u2013results from two experimental studies investigating cognitive immunization","volume":"49","author":"Kube","year":"2019","journal-title":"Psychol Med"},{"key":"10.3233\/JPD-212777_ref15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/07380577.2018.1558326","article-title":"Self-efficacy, self-regulation, social support, and outcomes expectations for daily physical activity in adults with chronic stroke: A descriptive, exploratory study","volume":"33","author":"Bailey","year":"2019","journal-title":"Occup Ther Health Care"},{"key":"10.3233\/JPD-212777_ref16","unstructured":"DeVellis R (2012) Scale development: Theory and applications (3rd ed.). SAGE, Thousand Oaks, CA."},{"key":"10.3233\/JPD-212777_ref17","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3928\/0048-5713-20020901-06","article-title":"The PHQ-9: A new depression and diagnostic severity measure","volume":"32","author":"Kroenke","year":"2002","journal-title":"Psychiatr Ann"},{"key":"10.3233\/JPD-212777_ref18","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/mds.25919","article-title":"The Parkinson Anxiety Scale (PAS): Development and validation of a new anxiety scale","volume":"29","author":"Leentjens","year":"2014","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-212777_ref19","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/08870449708406741","article-title":"The PDQ-8: Development and validation of a short-form Parkinson\u2019s disease questionnaire","volume":"12","author":"Jenkinson","year":"1997","journal-title":"Psychol Health"},{"key":"10.3233\/JPD-212777_ref22","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/arclin\/acx094","article-title":"Impaired self-awareness of motor disturbances in Parkinson\u2019s disease","volume":"32","author":"Maier","year":"2017","journal-title":"Arch Clin Neuropsychol"},{"key":"10.3233\/JPD-212777_ref23","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/mds.25079","article-title":"Impaired self-awareness of motor deficits in Parkinson\u2019s disease: Association with motor asymmetry and motor phenotypes","volume":"27","author":"Maier","year":"2012","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-212777_ref24","first-page":"159","volume-title":"Anosognosia and Parkinson\u2019s disease","author":"Prigatano","year":"2010"},{"key":"10.3233\/JPD-212777_ref25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s100720170066","article-title":"Unawareness of dyskinesias in Parkinson\u2019s and Huntington\u2019s diseases","volume":"22","author":"Vitale","year":"2001","journal-title":"Neurol Sci"},{"key":"10.3233\/JPD-212777_ref26","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.tins.2013.06.003","article-title":"Advances in the pharmacological treatment of Parkinson\u2019s disease: Targeting neurotransmitter systems","volume":"36","author":"Brichta","year":"2013","journal-title":"Trends Neurosci"},{"key":"10.3233\/JPD-212777_ref27","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1001\/archneurol.2011.182","article-title":"Ten-year outcome of subthalamic stimulation in Parkinson disease: A blinded evaluation","volume":"68","author":"Castrioto","year":"2011","journal-title":"Arch Neurol"},{"key":"10.3233\/JPD-212777_ref28","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1093\/brain\/awq221","article-title":"Motor and cognitive outcome in patients with Parkinson\u2019s disease 8 years after subthalamic implants","volume":"133","author":"Fasano","year":"2010","journal-title":"Brain"},{"key":"10.3233\/JPD-212777_ref29","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.parkreldis.2014.06.010","article-title":"The impact of STN deep brain stimulation on speech in individuals with Parkinson\u2019s disease: The patient\u2019s perspective","volume":"20","author":"Wertheimer","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-212777_ref30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1474-4422(12)70049-2","article-title":"Treatment of motor and non-motor features of Parkinson\u2019s disease with deep brain stimulation","volume":"11","author":"Fasano","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.3233\/JPD-212777_ref31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/brainsci6040058","article-title":"Improvement of advanced Parkinson\u2019s disease manifestations with deep brain stimulation of the subthalamic nucleus: A single institution experience","volume":"6","author":"Rabie","year":"2016","journal-title":"Brain Sci"},{"key":"10.3233\/JPD-212777_ref32","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.4103\/1673-5374.160094","article-title":"The treatment of Parkinson\u2019s disease with deep brain stimulation: Current issues","volume":"10","author":"Moldovan","year":"2015","journal-title":"Neural Regen Res"},{"key":"10.3233\/JPD-212777_ref33","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/brain\/aws078","article-title":"Subthalamic stimulation in Parkinson\u2019s disease: Restoring the balance of motivated behaviours","volume":"135","author":"Lhommee","year":"2012","journal-title":"Brain"},{"key":"10.3233\/JPD-212777_ref34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.parkreldis.2011.01.011","article-title":"Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation","volume":"17","author":"Williams","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-212777_ref35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jns.2018.04.002","article-title":"Dopaminergic dose adjustment and negative affective symptoms after deep brain stimulation","volume":"390","author":"Tareen","year":"2018","journal-title":"J Neurol Sci"},{"key":"10.3233\/JPD-212777_ref36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1155\/1993\/539179","article-title":"Anxiety and depression in Parkinson\u2019s disease","volume":"6","author":"Starkstein","year":"1993","journal-title":"Behav Neurol"},{"key":"10.3233\/JPD-212777_ref37","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1017\/S135246581800070X","article-title":"Modified mindfulness based cognitive therapy for depressive symptoms in Parkinson\u2019s disease: A pilot trial","volume":"47","author":"Rodgers","year":"2019","journal-title":"Behav Cogn Psychother"},{"key":"10.3233\/JPD-212777_ref38","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3233\/JPD-150542","article-title":"Cognitive behavior therapy for depression and anxiety disorders in Parkinson\u2019s disease","volume":"5","author":"Egan","year":"2015","journal-title":"J Parkinsons Dis"},{"key":"10.3233\/JPD-212777_ref39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-244X-14-19","article-title":"A wait-list controlled trial of group cognitive behavioral therapy for depression and anxiety in Parkinson\u2019s disease","volume":"14","author":"Troeung","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.3233\/JPD-212777_ref40","first-page":"106","article-title":"The interaction of locus of control, self-efficacy and outcome expectancy in relations to HbAic in medically underserved individuals with type 2 diabetes","volume":"32","author":"O\u2019Hara","year":"2008","journal-title":"J Behav Med"},{"key":"10.3233\/JPD-212777_ref41","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1440-172X.2008.00709.x","article-title":"Self-management in older patients with chronic illness","volume":"14","author":"Gallagher","year":"2008","journal-title":"Int J Nurs Pract"},{"key":"10.3233\/JPD-212777_ref42","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/mds.25689","article-title":"Clinical issues to consider in the treatment of anxiety and depression in older adults with Parkinson\u2019s disease","volume":"28","author":"Pachana","year":"2013","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-212777_ref43","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1521\/ijct.2008.1.3.192","article-title":"Repetitive negative thinking as a transdiagnostic process","volume":"1","author":"Ehring","year":"2008","journal-title":"Int J Cogn Ther"},{"key":"10.3233\/JPD-212777_ref44","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1177\/1740774512465064","article-title":"Development of the Stanford Expectations of Treatment Scale (SETS): A tool for measuring patient outcome expectancy in clinical trials","volume":"9","author":"Younger","year":"2012","journal-title":"Clin Trials"}],"container-title":["Journal of Parkinson's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JPD-212777","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:50:37Z","timestamp":1777611037000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JPD-212777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,12]]},"references-count":42,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jpd-212777","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,12]]}}}